EXOSOME MIT THERAPEUTISCHEN POLYPEPTIDEN

European patent · EP3463465 · In force

Register entry

Publication number
EP3463465
Application number
EP17727325
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 25, 2017
Published
Apr 10, 2019
Granted
Oct 14, 2020
Protection ends at the latest
May 24, 2037
Next annual fee due
May 31, 2027
IPC classes
A61K 47/69 (2017.01)
A61K 47/56 (2017.01)
A61K 41/00 (2020.01)
Priority
GB 201609216 25.05.2016
PCT application
PCT/GB2017/051479 25.05.2017
PCT publication
WO2017/203260 30.11.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Oct 14, 2020

    Granted

    Published in Swissreg on 14.10.2020

Parties

Holder

Evox Therapeutics Ltd

Oxford Science Park Medawar Centre 2nd Floor East Building Robert RobinsonAvenue, Oxford OX4 4HG, GB

Oxford University Innovation

Buxton Court 3 West Way, Oxford OX2 0JB, GB

Inventor

WIKLANDER, Oscar

16940 Solna, SE

WOOD, Matthew

Oxford OX2 6HY, GB

EL ANDALOUSSI, Samir

14131 Huddinge, SE

NORDIN, Joel

11762 Stockholm, SE

HEAN, Justin

Oxford OX2 7SS, GB

MAGER, Imre

Oxford OX2 0JW, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.